Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cathay Capital is a global private equity and venture capital investment platform with over $4 billion in assets under management. It specializes in cross-border investments supporting companies at all growth stages, particularly those expanding internationally. The group has completed over 150 buyouts, growth investments, and VC deals across sectors including healthcare/life sciences through its dedicated arms like Cathay Health and Cathay Innovation[3][5][8]. It does not develop drugs or therapies directly but invests in companies that do.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cathay Capital.